Continuous Connected Patient Care (CCPC), a Pilot Testing a Novel Device for Continuous Vitals Monitoring - Department of Anesthesia at PHC

March 10, 2026 updated by: Medtronic - MITG
To confirm feasibility and accessibility of the CCPC Platform (Oxymotion, Bridge Health Solutions medication adherence software, CloudDX home kit) in two different environments - in hospital and at-home, in patients undergoing non-cardiac surgery.

Study Overview

Status

Recruiting

Conditions

Study Type

Observational

Enrollment (Estimated)

50

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

Patients that have undergone a non-cardiac surgery requiring an inpatient hospital stay and peri-op patients who are in the Surgical High Acuity Unit (SHAU) at SPH.

Description

Inclusion Criteria:

  • 19 years or older
  • Patients that have undergone a non-cardiac surgery at SPH requiring an inpatient hospital stay
  • Peri-op patients who are in the Surgical High Acuity Unit (SHAU) and those followed by Anesthesia Perioperative Outreach team on the ward
  • Living within British Columbia, Canada and in an area that is covered by Bell cellular network

Exclusion Criteria:

  • Patient refusal
  • Lack of capacity to consent to the study (including having received sedative or general anesthetic within the past 24 hours)
  • Unable to use (or does not have a caregiver who can help put on) study monitoring device at home
  • Unable to complete (or does not have a caregiver who can help complete) study questionnaires by electronic (mobile, tablet, or computer), paper, nor phone
  • No access to cell phone nor landline at home to receive follow-ups
  • Preoperatively known to be discharged to a nursing home or rehabilitation facility
  • Known allergic reactions to any part material of study devices

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Collect patient and clinicians' feedback about the CCPC Platform
Time Frame: From enrollment to the end of follow up at 10 days
This will be completed via an assessment of the quantitative data on how long and how often patients use this monitoring and what were the reasons that patients took the monitors on and off.
From enrollment to the end of follow up at 10 days
Confirm the technical goals of the CCPC platform are met.
Time Frame: From enrollment to the end of follow up at 10 days
This will be completed by ensuring clinical workflow is met when using the monitoring platform.
From enrollment to the end of follow up at 10 days
Collect patient and clinicians' feedback about the CCPC Platform
Time Frame: From enrollment to the end of follow up at 10 days
This will be completed via an assessment of the Usability questionnaires.
From enrollment to the end of follow up at 10 days
Collect patient and clinicians' feedback about the CCPC Platform
Time Frame: From enrollment to the end of follow up at 10 days
This will be completed by an evaluation of potential harm, adverse events and safety issues.
From enrollment to the end of follow up at 10 days
Confirm the technical goals of the CCPC platform are met.
Time Frame: From enrollment to the end of follow up at 10 days
This will be completed via an assessment of the data flow: does the correct patient vitals information reach the clinicians at the right time?
From enrollment to the end of follow up at 10 days
Confirm the technical goals of the CCPC platform are met.
Time Frame: From enrollment to the end of follow up at 10 days
This will be completed by determining if the CCPC platform provided a holistic view of each patient with vitals, medication, and other collected data.
From enrollment to the end of follow up at 10 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Medtronic - MITG

Collaborators

Cloud DX Inc.
Providence Healthcare
Excelar
Bridge Health Solutions

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 13, 2025

Primary Completion (Estimated)

June 20, 2026

Study Completion (Estimated)

June 20, 2026

Study Registration Dates

First Submitted

September 16, 2024

First Submitted That Met QC Criteria

October 9, 2024

First Posted (Actual)

October 15, 2024

Study Record Updates

Last Update Posted (Actual)

March 12, 2026

Last Update Submitted That Met QC Criteria

March 10, 2026

Last Verified

May 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • H24-00862

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe